Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
68.76 USD | -0.74% | -7.79% | +9.49% |
05-22 | Vaxcyte Insider Sold Shares Worth $599,909, According to a Recent SEC Filing | MT |
05-14 | Transcript : Vaxcyte, Inc. Presents at Bank of America Health Care Conference 2024, May-14-2024 09:20 AM |
End-of-day quotes
Sector Bio Therapeutic Drugs
Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
---|---|---|---|---|---|---|
7.48B | - | - | - | - | - | |
118B | ||||||
106B | ||||||
23.4B | - | |||||
21.78B | - | |||||
18.09B |
- Stock Market
- Equities
- PCVX Stock
- Charts Vaxcyte, Inc.
- Sector Chart